Entrada Therapeutics Inc (TRDA)
$4.54 +3.07% Close Oct 30, 2026 Live
Entrada Therapeutics stock today
Entrada Therapeutics closed at $4.54 on October 30, 2026, up 3.07% on the day. Over the past year it returned -34.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $176 million.
$5.00$10.00$15.00
NovJan 2026MarMayJulSep
| Period | TRDA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -28.6% | -0.9% |
| 3 months | -33.0% | +2.1% |
| Year to date | -55.9% | +11.7% |
| 1 year | -34.3% | +12.4% |
| 3 years | -70.5% | +88.5% |
| 5 years | -81.1% | +76.0% |
Key statistics
- Market value
- $176M
- Price / sales
- 37.6
- 52-week range
- $4.37 to $16.03
- Next report
- Nov 5, 2026 (estimated)
About Entrada Therapeutics
Develops therapeutic antibody treatments for disease.
Sector: Health Care
More on Entrada Therapeutics
- Financials: revenue, earnings and segmentsRevenue -88% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $189.35 today
No forecast, no recommendation. This page describes Entrada Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.